Westrock Coffee (NASDAQ:WEST) Trading Down 5.7% – What’s Next?

Westrock Coffee (NASDAQ:WEST) shares fell 5.7% to about $7.45 on Thursday, after closing at $7.90. The stock traded as low as $7.38 on lighter volume. Analysts cited mixed views: Telsey raised its target to $9 and Stifel set $8. In its May 7 quarter, WEST reported EPS of -$0.04 vs -$0.13 expected on revenue of $308.83M.

Original reporting
Published Jun 4, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Westrock Coffee (NASDAQ:WEST) Trading Down 5.7% – What’s Next? — source image
Decision brief

The 30-second read

$WESTNeutralMed
01

Why it matters

WEST is reacting negatively on the day despite a recent EPS and revenue beat; analyst targets are mixed (some upgrades/holds, one outperform target up to $9, but still multiple sell/hold stances). Insider buying and institutional increases provide some support but don’t resolve the market’s concern about forward earnings power.

02

Market read

Traders can use today’s sharp decline alongside the May 7 earnings beat and mixed analyst revisions to frame near-term risk/reward for WEST.

03

What to watch

The article highlights negative profitability metrics (negative net margin/ROE) and a still-negative EPS outlook for the year, which can cap upside even after a single-quarter beat.

Relevance 8/10Novelty 5/10Timing: during/after today’s -5.7% selloff

Background

The article is a single-stock market-mover recap for Westrock Coffee (WEST), referencing its May 7 quarterly results and subsequent analyst actions.

Company-level read

Ticker impact

$WESTNeutralMedium confidence
Context

WEST shares fell 5.7% and the article cites its latest earnings beat, analyst target changes, and director insider buying.

Expected impact

Choppy, mean-reversion attempts are plausible, but downside risk remains until the market digests earnings quality and guidance for the year.

Evidence & confidence

The piece provides a fresh datapoint (today’s -5.7% move) and reiterates May 7 earnings (EPS beat, revenue beat) while also showing multiple sell/hold ratings and a director buy at $8.50—supportive but not enough to negate the market’s negative reaction.

Market effects

Limited read-across: coffee roasters/packagers may see sentiment spillover from WEST’s earnings reaction, but no sector-wide catalyst is cited.

None specified beyond US-listed trading.

None specified; company operations are global but the article is US-market focused.

Counterpoint

The earnings beat plus insider and several institutional adds could indicate the selloff is overdone and sets up a technical rebound attempt.

Key entities

  • Westrock Coffee Company

    US-listed coffee roaster/manufacturer; subject of the article’s price move, earnings recap, and ownership/analyst updates.

  • Joe T. Ford

    Director who bought 15,000 shares at an average $8.50 (Form 4 disclosure referenced).

Related articles

$WESTMedAI 8/10

Westrock Coffee (WEST) Q2 2026 Earnings Call Transcript

Westrock Coffee (WEST) reported Q2 2026 results on an earnings call. Consolidated net sales rose 8.8% to $305.7 million, led by Beverage Solutions. Adjusted EBITDA increased 38.9% to $21.3 million, and free cash flow was $20.2 million. Full-year 2026 adjusted EBITDA guidance was reaffirmed at $90 million to $100 million.

$WESTMed

Westrock Coffee Q2 Earnings Call Highlights

Westrock Coffee (NASDAQ:WEST) reported Q2 adjusted EBITDA of $21.3M, up about 39% YoY, and free cash flow of $20.2M. Management said single-serve cup volume rose over 9% YoY excluding lost business. The company reaffirmed 2026 adjusted EBITDA guidance of $90M to $100M and expects $30M capex in 2026.

$WESTMed

Westrock Coffee Co (WEST): Results of Operations and Financial Condition

Westrock Coffee Co (WEST) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ Westrock Coffee Company Reports Second Quarter 2026 Results and Reaffirms 2026 Outlook ​ LITTLE ROCK, Ark., August 6, 2026 (GLOBE NEWSWIRE) – Westrock Coffee Company (Nasdaq: WEST) (“Westrock Coffee” or the “Company”) today reported financial results for the second

$ROIVMedAI 8/10

What Lisraya’s $35,000 Monthly Price Could Mean for Roivant (ROIV)

Roivant Sciences (ROIV) and Priovant Therapeutics launched Lisraya, a $35,000/month dermatomyositis treatment, post-FDA approval. The drug's high price and small patient population present challenges, but its immediate launch and long exclusivity may drive adoption. ROIV owns 71% of Priovant, making Lisraya's success crucial for its financial outlook.

$BEMed

Bloom Energy (BE) Joins S&P 500: Can Its AI Rally Continue?

Bloom Energy (BE) will join the S&P 500 on September 21, effective before market open. The company's stock surged over 150% in 2026, driven by demand for its power solutions in AI data centers. Bloom Energy reported 166% revenue growth in Q2 and raised its full-year revenue outlook to $3.9B-$4.2B. The company has partnerships with Oracle and Brookfield Asset Management, aiming to accelerate fuel cell deployment.

$PCGMed

PG&E (PCG) and Edison (EIX) Sink After California Wildfire Liability Deal Falls Apart

PG&E (PCG) and Edison (EIX) shares fell after California lawmakers introduced a bill without liability protection for utilities. Analysts downgraded both stocks, and PG&E cut its 2027 capital investment plan by $2 billion. PG&E reaffirmed its FY 2026 earnings guidance and initiated FY 2027 guidance. Both companies face significant wildfire liability risks, with PG&E potentially covering 48% of the state's wildfire liability fund.